Compare TG Therapeutics Inc (TGTX) vs US Bancorp (USB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
TG Therapeutics Inc vs US Bancorp — how do they compare? TG Therapeutics Inc trades at $54 (market cap $8.26B), while US Bancorp trades at $63.14 (market cap $98.36B). The key difference: US Bancorp is far larger — about 11.9× TG Therapeutics Inc's market cap, and US Bancorp pays a 3.29% dividend while TG Therapeutics Inc pays none. Which is the better fit depends on your goals.
| TGTX | USB | |
|---|---|---|
Market Cap | $8.26B | $98.36B |
Sector | Health | Financials |
52-Week High | $59.06 | $64.01 |
52-Week Low | $26.39 | $43.94 |
Enterprise Value | $8.50B | — |
Dividend Yield | — | 3.29% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About TG Therapeutics Inc
TG Therapeutics is a fully integrated biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases. Its cornerstone product, BRIUMVI (ublituximab-xiiy), is a glycoengineered monoclonal antibody approved for relapsing forms of multiple sclerosis. The company is currently executing a 'pipeline-in-a-product' strategy, expanding BRIUMVI into new delivery methods and indications while advancing a broader portfolio of autoimmune and oncology candidates.
Read more on TGTX →About US Bancorp
As a diversified financial-services provider, U.S. Bancorp is one of the nation's largest regional banks, with branches in well over 20 states, primarily in the Western and Midwestern United States. The bank offers many services, including retail banking, commercial banking, trust and wealth services, credit cards, mortgages, and other payments capabilities.
Read more on USB →
